A therapy for Huntington's disease has shown sustained clinical benefit at 36 months. However, reports are unclear on the specifics of the therapy, with some outlets discussing different treatments and conditions, such as cell therapy for Parkinson's disease and a drug for essential tremor. The details and outcomes of the therapy are uncertain due to conflicting information across various outlets.